10-Year stability of clinical-grade serum-free γ-retroviral vector-containing medium

Gene Therapy

Volumn 18, Issue 2, 2011, Pages 210-212

  Herbst, F ^a   Ball, C R ^a   Zavidij, O ^a   Fessler, S ^a   Schmidt, M ^a   Veelken, H ^b   Von Kalle, C ^a   Glimm, H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

long term stability; retroviral vectors; serum free medium

Indexed keywords

CARBON DIOXIDE; CD34 ANTIBODY; RETROVIRUS VECTOR;

ARTICLE; BLOOD LEVEL; GENE TRANSFER; GIBBON LEUKEMIA VIRUS; GOOD MANUFACTURING PRACTICE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SERUM; SUPERNATANT; VIRAL GENE DELIVERY SYSTEM;

CULTURE MEDIA, SERUM-FREE; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; LEUKEMIA VIRUS, GIBBON APE; PRESERVATION, BIOLOGICAL; TIME FACTORS; TRANSDUCTION, GENETIC;

GIBBON APE LEUKEMIA VIRUS;

EID: 79951516696     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2010.126     Document Type: Article

References (17)

1. Glimm H, Flugge K, Mobest D, Hofmann VM, Postmus J, Henschler R et al. Efficient serum-free retroviral gene transfer into primitive human hematopoietic progenitor cells by a defined, high-titer, nonconcentrated vector-containing medium. Hum Gene Ther 1998; 9: 771-778. (Pubitemid 28197364)
2. Glimm H, Schmidt M, Fischer M, Schwarzwaelder K, Wissler M, Klingenberg S et al. Efficient marking of human cells with rapid but transient repopulating activity in autografted recipients. Blood 2005; 106: 893-898. (Pubitemid 41076429)
3. Lebkowski JS, Schain L, Hall M, Wysocki M, Dadey B, Biddle W. Rapid isolation and serum-free expansion of human CD34+ cells. Blood Cells 1994; 20: 404-410.
4. Springett GM, Moen RC, Anderson S, Blaese RM, Anderson WF. Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J Virol 1989; 63: 3865-3869. (Pubitemid 19205460)
5. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10: 4239-4242.
6. Roe T, Reynolds TC, Yu G, Brown PO. Integration of murine leukemia virus DNA depends on mitosis. EMBO J 1993; 12: 2099-2108. (Pubitemid 23157725)
7. Takeuchi Y, Cosset FL, Lachmann PJ, Okada H, Weiss RA, Collins MK. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J Virol 1994; 68: 8001-8007. (Pubitemid 24362688)
8. DePolo NJ, Harkleroad CE, Bodner M, Watt AT, Anderson CG, Greengard JS et al. The resistance of retroviral vectors produced from human cells to serum inactivation in vivo and in vitro is primate species dependent. J Virol 1999; 73: 6708-6714. (Pubitemid 29327853)
9. Cosset FL, Takeuchi Y, Battini JL, Weiss RA, Collins MK. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430-7436.
10. Pensiero MN, Wysocki CA, Nader K, Kikuchi GE. Development of amphotropic murine retrovirus vectors resistant to inactivation by human serum. Hum Gene Ther 1996; 7: 1095-1101. (Pubitemid 26202727)
11. Beer C, Meyer A, Muller K, Wirth M. The temperature stability of mouse retroviruses depends on the cholesterol levels of viral lipid shell and cellular plasma membrane. Virology 2003; 308: 137-146. (Pubitemid 36428972)
12. Cruz PE, Silva AC, Roldao A, Carmo M, Carrondo MJ, Alves PM. Screening of novel excipients for improving the stability of retroviral and adenoviral vectors. Biotechnol Prog 2006; 22: 568-576.
13. Wikstrom K, Blomberg P, Islam KB. Clinical grade vector production: analysis of yield, stability, and storage of gmp-produced retroviral vectors for gene therapy. Biotechnol Prog 2004; 20: 1198-1203. (Pubitemid 39059634)
14. Lamers CH, Van Elzakker P, Luider BA, Van Steenbergen SC, Sleijfer S, Debets R et al. Retroviral vectors for clinical immunogene therapy are stable for up to 9 years. Cancer Gene Ther 2008; 15: 268-274. (Pubitemid 351367559)
15. Miller AD, Garcia JV, von Suhr N, Lynch CM, Wilson C, Eiden MV. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol 1991; 65: 2220-2224.
16. Higashikawa F, Chang L. Kinetic analyses of stability of simple and complex retroviral vectors. Virology 2001; 280: 124-131. (Pubitemid 34158058)
17. Nyberg-Hoffman C, Aguilar-Cordova E. Instability of adenoviral vectors during transport and its implication for clinical studies. Nat Med 1999; 5: 955-957. (Pubitemid 29372426)